CENTURY THERAPEUTICS INC's ticker is IPSC and the CUSIP is 15673T100. A total of 57 filers reported holding CENTURY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $421,173 | -74.2% | 82,100 | -50.3% | 0.00% | -85.7% |
Q3 2022 | $1,634,000 | -59.6% | 165,200 | -65.7% | 0.01% | -58.8% |
Q2 2022 | $4,040,000 | -31.3% | 481,000 | +2.9% | 0.02% | -26.1% |
Q1 2022 | $5,884,000 | -9.7% | 467,390 | +13.8% | 0.02% | -11.5% |
Q4 2021 | $6,515,000 | – | 410,800 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 602,623 | $15,162,000 | 3.73% |
Casdin Capital, LLC | 3,206,380 | $80,673,000 | 2.01% |
Logos Global Management LP | 639,095 | $16,080,000 | 1.16% |
Parametrica Management Ltd | 28,755 | $723,000 | 0.54% |
DAFNA Capital Management LLC | 80,000 | $2,013,000 | 0.53% |
Avidity Partners Management LP | 739,269 | $18,600,000 | 0.41% |
RA Capital Management | 914,094 | $22,999,000 | 0.32% |
HHLR ADVISORS, LTD. | 614,095 | $15,451,000 | 0.20% |
Orbimed Advisors | 407,047 | $10,241,000 | 0.11% |
Woodline Partners LP | 250,094 | $6,292,000 | 0.10% |